These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 29436899)

  • 21. A major role for capsule-independent phagocytosis-inhibitory mechanisms in mammalian infection by Cryptococcus neoformans.
    Chun CD; Brown JCS; Madhani HD
    Cell Host Microbe; 2011 Mar; 9(3):243-251. PubMed ID: 21402362
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Difference in Cryptococcus neoformans cellular and capsule size in sequential pulmonary and meningeal infection: a postmortem study.
    Xie S; Sao R; Braun A; Bottone EJ
    Diagn Microbiol Infect Dis; 2012 May; 73(1):49-52. PubMed ID: 22424901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of allergen 1 confers a hypervirulent phenotype that resembles mucoid switch variants of Cryptococcus neoformans.
    Jain N; Li L; Hsueh YP; Guerrero A; Heitman J; Goldman DL; Fries BC
    Infect Immun; 2009 Jan; 77(1):128-40. PubMed ID: 18955480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of App1 as a regulator of phagocytosis and virulence of Cryptococcus neoformans.
    Luberto C; Martinez-Mariño B; Taraskiewicz D; Bolaños B; Chitano P; Toffaletti DL; Cox GM; Perfect JR; Hannun YA; Balish E; Del Poeta M
    J Clin Invest; 2003 Oct; 112(7):1080-94. PubMed ID: 14523045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The capsule of the fungal pathogen Cryptococcus neoformans.
    Zaragoza O; Rodrigues ML; De Jesus M; Frases S; Dadachova E; Casadevall A
    Adv Appl Microbiol; 2009; 68():133-216. PubMed ID: 19426855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rheological properties of cryptococcal polysaccharide change with fiber size, antibody binding and temperature.
    de S Araújo GR; Viana NB; Pontes B; Frases S
    Future Microbiol; 2019 Jul; 14():867-884. PubMed ID: 31340660
    [No Abstract]   [Full Text] [Related]  

  • 27. The origin and maintenance of virulence for the human pathogenic fungus Cryptococcus neoformans.
    Steenbergen JN; Casadevall A
    Microbes Infect; 2003 Jun; 5(7):667-75. PubMed ID: 12787743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phenotypic switching in Cryptococcus neoformans.
    Guerrero A; Jain N; Goldman DL; Fries BC
    Microbiology (Reading); 2006 Jan; 152(Pt 1):3-9. PubMed ID: 16385110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polysaccharide antigens of the capsule of Cryptococcus neoformans.
    Cherniak R; Sundstrom JB
    Infect Immun; 1994 May; 62(5):1507-12. PubMed ID: 8168912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of signal transduction pathways related to the pathogenicity of Cryptococcus neoformans in the host environment.
    Matsumoto Y; Azami S; Shiga H; Nagamachi T; Moriyama H; Yamashita Y; Yoshikawa A; Sugita T
    Drug Discov Ther; 2019; 13(4):177-182. PubMed ID: 31534068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Wor1-Like Transcription Factor Is Essential for Virulence of
    Paes HC; Derengowski LDS; Peconick LDF; Albuquerque P; Pappas GJ; Nicola AM; Silva FBA; Vallim MA; Alspaugh JA; Felipe MSS; Fernandes L
    Front Cell Infect Microbiol; 2018; 8():369. PubMed ID: 30483479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 'Ready made' virulence and 'dual use' virulence factors in pathogenic environmental fungi--the Cryptococcus neoformans paradigm.
    Casadevall A; Steenbergen JN; Nosanchuk JD
    Curr Opin Microbiol; 2003 Aug; 6(4):332-7. PubMed ID: 12941400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans.
    Doering TL
    Annu Rev Microbiol; 2009; 63():223-47. PubMed ID: 19575556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Xylose donor transport is critical for fungal virulence.
    Li LX; Rautengarten C; Heazlewood JL; Doering TL
    PLoS Pathog; 2018 Jan; 14(1):e1006765. PubMed ID: 29346417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maintenance of Mitochondrial Morphology in Cryptococcus neoformans Is Critical for Stress Resistance and Virulence.
    Chang AL; Doering TL
    mBio; 2018 Nov; 9(6):. PubMed ID: 30401774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cryptococcus neoformans induces antimicrobial responses and behaves as a facultative intracellular pathogen in the non mammalian model Galleria mellonella.
    Trevijano-Contador N; Herrero-Fernández I; García-Barbazán I; Scorzoni L; Rueda C; Rossi SA; García-Rodas R; Zaragoza O
    Virulence; 2015; 6(1):66-74. PubMed ID: 25531532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Receptor-mediated recognition of Cryptococcus neoformans.
    Levitz SM
    Nihon Ishinkin Gakkai Zasshi; 2002; 43(3):133-6. PubMed ID: 12145626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurovirulence of Cryptococcus neoformans determined by time course of capsule accumulation and total volume of capsule in the brain.
    Pool A; Lowder L; Wu Y; Forrester K; Rumbaugh J
    J Neurovirol; 2013 Jun; 19(3):228-38. PubMed ID: 23733307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cryptococcus neoformans: virulence and host defences.
    Perfect JR; Wong B; Chang YC; Kwon-Chung KJ; Williamson PR
    Med Mycol; 1998; 36 Suppl 1():79-86. PubMed ID: 9988495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unusual galactofuranose modification of a capsule polysaccharide in the pathogenic yeast Cryptococcus neoformans.
    Heiss C; Skowyra ML; Liu H; Klutts JS; Wang Z; Williams M; Srikanta D; Beverley SM; Azadi P; Doering TL
    J Biol Chem; 2013 Apr; 288(16):10994-1003. PubMed ID: 23408430
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.